D'Alimonte, Iolanda <br/><br/>
Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.  [electronic resource] 

 -  Purinergic signalling  Sep 2015 
 - 331-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-9546 
<br/><br/><label>Standard No.: </label>10.1007/s11302-015-9454-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine A3 Receptor Antagonists--pharmacology<br/>Adenosine Triphosphate--analogs & derivatives<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>Brain Neoplasms--drug therapy<br/>Caspase Inhibitors--pharmacology<br/>Cell Proliferation<br/>Dacarbazine--analogs & derivatives<br/>Drug Synergism<br/>Glioblastoma--drug therapy<br/>Humans<br/>Ligands<br/>Neoplastic Stem Cells--drug effects<br/>Purinergic P2Y Receptor Antagonists--pharmacology<br/>Receptors, Purinergic--drug effects<br/>Receptors, Purinergic P1--drug effects<br/>Receptors, Purinergic P2X7--drug effects<br/>Temozolomide